Lactobacillus casei alters hPEPT1-mediated glycylsarcosine uptake in Caco-2 cells

被引:10
作者
Neudeck, BL [1 ]
Loeb, JM
Faith, NG
机构
[1] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA
[2] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA
关键词
hPEPT1; Lactobacillus casei; Caco-2; cells; glycylsarcosine;
D O I
10.1093/jn/134.5.1120
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Augmentation of the normal flora of the gastrointestinal tract with probiotic bacteria is currently under investigation as a therapeutic tool for several diseases. However, it is unknown whether probiotic bacteria such as Lactobacillus casei alter the expression and function of intestinal transport proteins such as hPEPT1. The effects of 24 and 48 h incubation of Caco-2 cells with 10(8)/L L. casei on the hPEPT1-mediated uptake rate of 20 mumol/L [H-3]glycylsarcosine were examined. Dipeptide uptake did not differ from the control at 24 h (15.9 +/- 2.4 vs. 11.5 +/- 1.4 cm (.) s(-1 .) mg protein(-1)); however, a significant increase in uptake occurred after 48 h of L. casei treatment (23.7 +/- 1.5 vs. 12.0 +/- 1.9 cm (.) s(-1) (.) mg protein(-1); P = 0.005). hPEPT1 involvement was confirmed in experiments using excess substrate. Increased uptake of [H-3]glycylsarcosine appeared to be the result of the direct interaction of the bacteria with Caco-2 cells because conditioned medium had no effect on dipeptide uptake. hPEPT1 mRNA levels did not differ at any time point. These results show that prolonged incubation of Caco-2 cells leads to increased hPEPT1 activity and that this occurs by a mechanism distinct from increased gene expression.
引用
收藏
页码:1120 / 1123
页数:4
相关论文
共 23 条
[11]   Probiotics inhibit enteropathogenic E-coli adherence in vitro by inducing intestinal mucin gene expression [J].
Mack, DR ;
Michail, S ;
Wei, S ;
McDougall, L ;
Hollingsworth, MA .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 276 (04) :G941-G950
[12]   Probiotic bacteria enhance murine and human intestinal epithelial barrier function [J].
Madsen, K ;
Cornish, A ;
Soper, P ;
McKaigney, C ;
Jijon, H ;
Yachimec, C ;
Doyle, J ;
Jewell, L ;
De Simone, C .
GASTROENTEROLOGY, 2001, 121 (03) :580-591
[13]   Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model [J].
Mattar, AF ;
Teitelbaum, DH ;
Drongowski, RA ;
Yongyi, F ;
Harmon, CM ;
Coran, AG .
PEDIATRIC SURGERY INTERNATIONAL, 2002, 18 (07) :586-590
[14]   Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection [J].
Michail, S ;
Abernathy, F .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 (03) :350-355
[15]   PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of Cefadroxil longitudinally in the rat intestine [J].
Naruhashi, K ;
Sai, Y ;
Tamai, I ;
Suzuki, N ;
Tsuji, A .
PHARMACEUTICAL RESEARCH, 2002, 19 (10) :1417-1423
[16]   Di/tri-peptide transporters as drug delivery targets: Regulation of transport under physiological and patho-physiological conditions [J].
Nielsen, CU ;
Brodin, B .
CURRENT DRUG TARGETS, 2003, 4 (05) :373-388
[17]   HUMAN INTESTINAL H+/PEPTIDE COTRANSPORTER - CLONING, FUNCTIONAL EXPRESSION, AND CHROMOSOMAL LOCALIZATION [J].
RONG, LA ;
FEI, YJ ;
PRASAD, PD ;
RAMAMOORTHY, S ;
HAN, H ;
YANGFENG, TL ;
HEDIGER, MA ;
GANAPATHY, V ;
LEIBACH, FH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) :6456-6463
[18]   Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children [J].
Shornikova, AV ;
Casas, IA ;
Isolauri, E ;
Mykkanen, H ;
Vesikari, T .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997, 24 (04) :399-404
[19]   Hormonal regulation of oligopeptide transporter Pept-1 in a human intestinal cell line [J].
Thamotharan, M ;
Bawani, SZ ;
Zhou, XD ;
Adibi, SA .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (04) :C821-C826
[20]   ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR TRANSPORT IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
THWAITES, DT ;
CAVET, M ;
HIRST, BH ;
SIMMONS, NL .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (05) :981-986